IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Beneish M-Score: -2.05 (As of Jun. 25, 2026)


NSE:IOLCP IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
68 GF Score
Price ₹133.66
GF Value ₹93.62
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is IOL Chemicals And Pharmaceuticals Beneish M-Score?

IOL Chemicals And Pharmaceuticals NSE:IOLCP +2.06% 68 Beneish M-Score is -2.05 as of Jun. 25, 2026. GuruFocus rates NSE:IOLCP with a GF Score™ of 68/100 and a GF Value™ of ₹93.62 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 911 Drug Manufacturers companies, IOL Chemicals And Pharmaceuticals ranks worse than 76.73% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.05 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for IOL Chemicals And Pharmaceuticals's Beneish M-Score or its related term are showing as below:

NSE:IOLCP' s Beneish M-Score Range Over the Past 10 Years
Min: -6.91   Med: -2.36   Max: 0.51
Current: -2.05

During the past 13 years, the highest Beneish M-Score of IOL Chemicals And Pharmaceuticals was 0.51. The lowest was -6.91. And the median was -2.36.


IOL Chemicals And Pharmaceuticals Beneish M-Score Historical Data

* Premium members only.

The historical data trend for IOL Chemicals And Pharmaceuticals's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IOL Chemicals And Pharmaceuticals Beneish M-Score Chart

IOL Chemicals And Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.51 -2.26 -3.26 -2.78 -2.05

IOL Chemicals And Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.78 0.00 0.00 0.00 -2.05

NSE:IOLCP vs ZTS: Beneish M-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, IOL Chemicals And Pharmaceuticals's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IOL Chemicals And Pharmaceuticals Beneish M-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, IOL Chemicals And Pharmaceuticals's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where IOL Chemicals And Pharmaceuticals's Beneish M-Score falls into.


NSE:IOLCP
68GF Score
IOL Chemicals And Pharmaceuticals Ltd NSE:IOLCP
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IOL Chemicals And Pharmaceuticals Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of IOL Chemicals And Pharmaceuticals for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0128+0.528 * 0.9215+0.404 * 1.8581+0.892 * 1.1154+0.115 * 0.9602
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0+4.679 * -0.029641-0.327 * 1.0456
=-2.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was ₹6,031 Mil.
Revenue was ₹23,191 Mil.
Gross Profit was ₹8,320 Mil.
Total Current Assets was ₹12,276 Mil.
Total Assets was ₹25,870 Mil.
Property, Plant and Equipment(Net PPE) was ₹12,624 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹802 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹6,902 Mil.
Long-Term Debt & Capital Lease Obligation was ₹24 Mil.
Net Income was ₹1,376 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹2,143 Mil.
Total Receivables was ₹5,339 Mil.
Revenue was ₹20,792 Mil.
Gross Profit was ₹6,874 Mil.
Total Current Assets was ₹11,513 Mil.
Total Assets was ₹23,821 Mil.
Property, Plant and Equipment(Net PPE) was ₹11,827 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹720 Mil.
Selling, General, & Admin. Expense(SGA) was ₹679 Mil.
Total Current Liabilities was ₹6,099 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(6031.3 / 23190.6) / (5339.4 / 20792.1)
=0.260075 / 0.256799
=1.0128

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(6873.6 / 20792.1) / (8319.8 / 23190.6)
=0.330587 / 0.358757
=0.9215

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (12276.3 + 12624) / 25869.5) / (1 - (11513.4 + 11827) / 23820.7)
=0.037465 / 0.020163
=1.8581

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=23190.6 / 20792.1
=1.1154

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(719.9 / (719.9 + 11827)) / (802.3 / (802.3 + 12624))
=0.057377 / 0.059756
=0.9602

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(0 / 23190.6) / (678.6 / 20792.1)
=0 / 0.032637
=0

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((24 + 6901.8) / 25869.5) / ((0 + 6099.1) / 23820.7)
=0.267721 / 0.256042
=1.0456

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1376.4 - 0 - 2143.2) / 25869.5
=-0.029641

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

IOL Chemicals And Pharmaceuticals has a M-score of -2.05 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.05 mean?
IOL Chemicals And Pharmaceuticals (NSE:IOLCP) has a Beneish M-Score of -2.05 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. According to the industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #699 out of 911 companies in the Drug Manufacturers industry, placing it in the top 76.7%.
Is IOL Chemicals And Pharmaceuticals' Beneish M-Score too high?
IOL Chemicals And Pharmaceuticals' current Beneish M-Score is -2.05. Based on the distribution chart, IOL Chemicals And Pharmaceuticals ranks #699 out of 911 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, IOL Chemicals And Pharmaceuticals has a GF Score™ of 68/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does IOL Chemicals And Pharmaceuticals' Beneish M-Score compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IOL Chemicals And Pharmaceuticals ranks #699 out of 911 companies for Beneish M-Score. This places IOL Chemicals And Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Drug Manufacturers company?
A good Beneish M-Score depends on the Drug Manufacturers industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on IOL Chemicals And Pharmaceuticals and its competitors. IOL Chemicals And Pharmaceuticals's current Beneish M-Score is -2.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IOL Chemicals And Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals (NSE:IOLCP) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹93.62, compared to a current price of ₹133.66 — trading 42.8% above its estimated fair value. The current Beneish M-Score is -2.05. IOL Chemicals And Pharmaceuticals' overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For IOL Chemicals And Pharmaceuticals (NSE:IOLCP), the current Beneish M-Score is -2.05 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IOL Chemicals And Pharmaceuticals (NSE:IOLCP) Overvalued in 2026?

Based on GuruFocus' analysis, IOL Chemicals And Pharmaceuticals stock appears to be overvalued. The current stock price of ₹133.66 is trading 42.8% above its estimated GF Value™ of ₹93.62. GuruFocus considers IOL Chemicals And Pharmaceuticals to be Significantly Overvalued.

Key valuation signals for NSE:IOLCP:

  • Beneish M-Score: -2.05
  • GF Value™: ₹93.62 vs. price of ₹133.66 (42.8% above fair value)
  • GF Score™: 68/100 with 5 warning signs

No single metric tells the full story. See the NSE:IOLCP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IOL Chemicals And Pharmaceuticals Business Description

Other Exchanges 524164:India
Address 85, Industrial Area, A, Ludhiana, PB, IND, 141 003
IOL Chemicals And Pharmaceuticals Ltd is an India-based pharmaceutical company. The primary activity of the group is the manufacturing and sale of drugs and organic chemicals. The business activity is functioned through the Chemicals and Pharmaceutical segments. The Chemicals segment produces and sells chemicals such as Ethyl Acetate, Acetic Anhydride, Acetyl Chloride, Mono Chloro Acetic Acid, and Iso Butyl benzene, whereas the Pharmaceutical segment produces and sells various active pharmaceutical ingredients such as Ibuprofen, Metformin, Fenofibrate, Lamotrigine, and others. It derives prime revenue from the Pharmaceutical segment. Geographically, the group's products are sold in both the Indian and international markets.
68GF Score

Get the complete analysis for NSE:IOLCP

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹133.66
Price
₹93.62
GF Value